Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema

Introduction. Diabetic retinopathy is the most common cause of visual loss and blindness in the age group of 20 to 64 years. This study aimed to evaluate the efficacy of oral Losartan adjuvant therapy in combination with intravitreal injection of Bevacizumab in the treatment of diabetic macular edem...

Full description

Bibliographic Details
Main Authors: Fariba Ghassemi, Abdulrahim Amini, Masoud Yasemi, Amin Nabavi, Mohammadkarim Johari
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2020/4528491